Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Durbactagene Autoleucel and Drug Combination for Adults with Relapsed and Refractory Multiple Myeloma

    Not recruiting

    1 1 1
    France Germany Greece Italy Spain
  • Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

    Not recruiting

    1 1 1 1
    Austria Belgium Czechia Denmark France Germany +6
  • Study of Elranatamab for Treating Relapsed or Refractory Multiple Myeloma in Patients Previously Treated with Three Drug Classes

    Not recruiting

    1 1
    Investigated drugs:
    Spain
  • Study on Human Normal Immunoglobulin to Prevent Early Infections in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    1 1 1
    Investigated drugs:
    Denmark Estonia Norway
  • Study on the Safety and Effects of Forimtamig, Tocilizumab, and Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1
    Denmark France Germany Italy Spain
  • Study on Venetoclax, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1
    Hungary Spain
  • Study of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Czechia Denmark France Germany Greece +7
  • Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant

    Not recruiting

    1 1 1 1
    Czechia France Germany The Netherlands Poland Spain
  • Study Comparing Venetoclax and Dexamethasone with Pomalidomide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Czechia Denmark France Germany Greece Italy +1
  • Long-term Safety Study of Daratumumab with Drug Combination for Patients with Multiple Myeloma or Smoldering Multiple Myeloma

    Not recruiting

    1 1 1 1
    Belgium Czechia Denmark France Germany Greece +3